Loading
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Sept 2019 for PROGENICS PHARMACEUTICALS INC, €326k.
Filing timeline
BuySaleVelan Capital, L.P.
Insider track record
Disclosed buys
5
Disclosed sells
0
Signal history
Closed purchases
Market purchases
5
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Velan Capital, L.P.: trading record in brief
This profile gathers the share dealings of Velan Capital, L.P. in Progenics Pharmaceuticals Inc. The record holds 5 filings, for trades running from 23 August 2019 to 9 September 2019.
No open-market sale appears; the market trades are 5 purchases worth €3.2M. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
In size, the median ticket on the buying side is €509k. Clusters matter here: 1 out of 5 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.
The newest entry dates from 11 September 2019: an open-market purchase of €326k, in Progenics Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Velan Capital, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
72,023 shares@ US$4.994710.1% of flowCommon Stock, $0.0013 par valueSEC:0000921895-19-002393:0
Canonical exit: 8 Dec 2019 (T+90)
277,424 shares@ US$4.393734.5% of flowCommon Stock, $0.0013 par valueSEC:0000921895-19-002367:0
Canonical exit: 2 Dec 2019 (T+90)
243,614 shares@ US$4.509330.9% of flowCommon Stock, $0.0013 par valueSEC:0000921895-19-002367:1
Canonical exit: 3 Dec 2019 (T+90)
130,826 shares@ US$4.308715.8% of flowCommon Stock, $0.0013 par valueSEC:0000921895-19-002346:0
Canonical exit: 21 Nov 2019 (T+90)
73,230 shares@ US$4.30038.8% of flowCommon Stock, $0.0013 par valueSEC:0000921895-19-002346:1
Canonical exit: 24 Nov 2019 (T+90)
5 of 5 declarations
